市场调查报告书
商品编码
1521163
颅内支架市场报告按类型(自扩张支架、球囊扩张支架、支架辅助线圈栓塞)、应用(颅内狭窄、脑动脉瘤)、最终用户(医院、门诊手术中心)和地区2024-2032Intracranial Stents Market Report by Type (Self-Expanding Stents, Balloon Expanding Stents, Stent-Assisted Coil Embolization), Application (Intracranial Stenosis, Brain Aneurysm), End User (Hospitals, Ambulatory Surgery Centers), and Region 2024-2032 |
IMARC Group年,全球颅内支架市场规模达到4.275亿美元。各种脑血管疾病的盛行率不断上升,老年人口迅速增长,以及患者和医疗保健提供者对非侵入性和微创手术的偏好转变,是推动市场的一些关键因素。
颅内支架是指由镍钛诺或不銹钢等生物相容性材料製成的小型管状医疗器械,专门设计用于以侵入性较小的方式治疗各种脑血管疾病。它们的特点是提高了与多种成像技术的兼容性,允许在血管中精确导航,因此可以部署在目标部位,并具有各种尺寸和配置,以适应个体的解剖特征。它们最常安装在大脑中狭窄或薄弱的血管内,以提供结构支撑并恢復血流。透过保持血管通畅,它们可以增强大脑的血流量,有助于降低中风和与血管受限或受损相关的其他併发症的风险。颅内支架广泛应用于血管成形术或血管内弹簧圈等手术和程序中,以治疗包括颅内动脉瘤或狭窄在内的各种病症。颅内支架的一些优点包括对血管的长期支持、更短的恢復时间和减少住院时间。
全球市场主要受到脑动脉瘤和中风等各种脑血管疾病盛行率上升的推动。这可以归因于老年人口的快速增长,他们更容易患上这些疾病。与此一致的是,颅内支架生产技术的不断进步,带来了具有更高灵活性、可导航性和径向强度的创新和先进产品,正在推动市场发展。此外,对神经系统疾病的早期诊断和治疗的日益重视正在推动对有效治疗解决方案的需求,这反过来又导致颅内支架的使用率更高。此外,患者和医疗保健提供者对恢復时间较短的非侵入性和微创手术的偏好的转变也是市场成长的重要诱导因素。除此之外,一些国家的政府机构和私人保险公司对颅内支架手术的优惠报销政策正在创造积极的市场前景。主要参与者之间为扩大市场份额而进行的各种策略合作、併购 (M&A) 和合作伙伴关係进一步推动了市场的发展。除此之外,磁振造影(MRI)、电脑断层扫描(CT)和血管摄影等医学影像技术的众多创新正在对市场产生积极影响。促进市场发展的其他一些因素包括快速城市化、医疗保健支出增加、医院基础设施升级(特别是在发展中国家)以及广泛的研发(R&D)活动。
The global intracranial stents market size reached US$ 427.5 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,099.9 Million by 2032, exhibiting a growth rate (CAGR) of 10.74% during 2024-2032. The rising prevalence of various cerebrovascular disorders, rapidly growing geriatric population, and shifting preference among patients and healthcare providers towards non-invasive and minimally invasive procedures represent some of the key factors driving the market.
Intracranial stents refer to small, tubular medical devices that are made from biocompatible materials such as nitinol or stainless steel, specifically designed for treating various cerebrovascular conditions in a less invasive way. They are characterized by improved compatibility with multiple imaging techniques, allowing precise navigation through blood vessels and are therefore deployed at the target site, with various sizes and configurations available to accommodate individual anatomical features. They are most commonly installed within narrowed or weakened blood vessels in the brain to provide structural support and restore blood flow. By maintaining vessel patency, they provide enhanced blood flow to the brain which helps in reducing the risk of stroke and other complications associated with restricted or damaged blood vessels. Intracranial stents find extensive applications in surgeries and procedures such as angioplasty or endovascular coiling, to treat various conditions including intracranial aneurysms or stenosis. Some of the advantages provided by intracranial stents include long-term support to blood vessels, shorter recovery times, and reduced hospital stays.
The global market is primarily driven by the rising prevalence of various cerebrovascular disorders such as cerebral aneurysms and strokes. This can be attributed to the rapidly growing geriatric population that is more susceptible to developing these ailments. In line with this, continual technological advancements in intracranial stent production resulting in innovative and advanced products with improved flexibility, navigability, and radial strength are fueling the market. Moreover, an enhanced emphasis on early diagnosis and treatment of neurological conditions is propelling the demand for effective treatment solutions, which in turn is resulting in a higher uptake of intracranial stents. Also, the shifting preference among patients and healthcare providers towards non-invasive and minimally invasive procedures with shorter recovery times is acting as a significant growth-inducing factor for the market. In addition to this, favorable reimbursement policies for intracranial stent procedures by government agencies and private insurance providers in several countries is creating a positive market outlook. The market is further fueled by various strategic collaborations, merger and acquisitions (M&As) and partnerships among key players to expand their market presence. Apart from this, numerous innovations in medical imaging technologies, such as magnetic resonance imaging (MRI), computed tomography (CT), and angiography are impacting the market positively. Some of the other factors contributing to the market include rapid urbanization, rising healthcare expenditure, upgradation of hospital infrastructure, particularly in developing countries and extensive research and development (R&D) activities.
IMARC Group provides an analysis of the key trends in each segment of the global intracranial stents market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on type, application, and end user.
Self-Expanding Stents
Balloon Expanding Stents
Stent-Assisted Coil Embolization
The report has provided a detailed breakup and analysis of the intracranial stents market based on the type.This includes self-expanding stents, balloon expanding stents, and stent-assisted coil embolization. According to the report, self-expanding stents represented the largest segment.
Intracranial Stenosis
Brain Aneurysm
The report has provided a detailed breakup and analysis of the intracranial stents market based on the application. This includes intracranial stenosis and brain aneurysm. According to the report, intracranial stenosis represented the largest segment.
Hospitals
Ambulatory Surgery Centers
A detailed breakup and analysis of the intracranial stents market based on the end user has also been provided in the report. This includes hospitals and ambulatory surgery centers. According to the report, hospitals accounted for the largest market share.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for intracranial stents. Some of the factors driving the North America intracranial stents market included growing geriatric population, continual technological advancements, shifting preference towards non-invasive and minimally invasive procedures, high healthcare expenditure, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global intracranial stents market. Detailed profiles of all major companies have been provided. Some of the companies covered include Acandis GmbH, Balt Group, Medtronic Public Limited Company, MicroPort Scientific Corporation, Phenox GmbH, Stryker Corporation, Terumo Corporation, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.